ARCX:SBIO - ETF Fact Sheet

ALPS Medical Breakthroughs ETF - USD

Fund Identification

Ticker

ARCX:SBIO

ISIN

US00162Q5936

Main Metrics

Price

$65.12

Expense Ratio

0.5%

AuM

$206.76M

Tracking Difference

0.12%

Ratings

Trackinsight rating

★★★★★

Official Investment Strategy

The ALPS Medical Breakthroughs ETF invests in the public equity markets of the United States. It invests in the stocks of companies operating in the biotechnology and pharmaceutical sectors. The fund invests in stocks of mid cap and small cap companies with a market capitalization of no less than $200 million and no more than $5 billion. It seeks to replicate the performance of the S-Network Medical Breakthroughs Index, by investing in the stocks of companies as per their weightings in the index.

ARCX:SBIO's historical prices, performance, and flows

1m returns

22%

1m flows

$18M

Get more in-depth data and information about ARCX:SBIO on Trackinsight

* Net total returns

All data as of 17 July 2026

The ETF Exchange is brought to you by

With data and analysis by

See all ARCX:SBIO data with a
free P&I Online account

Enjoy unlimited ETF searches and access to tear-sheets of over 4,000 North-American funds.

or Login

ARCX:SBIO's characteristics

Manager

ALPS

Manager statistics

23 funds, $20.6Bn in AUM

Benchmark

S-Network Medical Breakthroughs Index NTR - USD

Replication method

Direct (Physical)

Asset class

Equity

Dividend policy

Distributing

ARCX:SBIO's exposure

The ARCX:SBIO ETF provides physical exposure, so by buying it you actually own parts of all the underlying holdings. We're working to retrieve all detailed holdings information.